Hepatitis

Selected Books and Book Chapters:

1. De Groot AS, Liebel S (2005). "Hepatitis B and hepatitis C among offenders within prisons (Chapter)." In: Stojkovic S (Ed.), Managing Special Populations in Jails and Prisons. Milwaukee, Civic Research Institute: 209-223.

2. Taylor L, Schwartzapfel B, Gholam PM (2006). "Limiting Harm from Chronic Hepatitis C Infection for HIV-Positive People with Drug Dependency: Prevention and Treatment." In: Pizer HF, Mayer K (Ed.), Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. New York, N.Y., Open Society Institute: 95-109.

Peer-Reviewed Publications:

1. Rich JD, Chin-Hong PV, Busi KA, et al. (1997). "Hepatitis C and HIV in male prisoners." J Acquir Immune Defic Syndr Hum Retrovirol 16(5):408-409.

2. Rich JD, Dickinson BP, Merriman NA, et al. (1998). "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." Am J Gastroenterol 93(9):1598.

3. Rich JD, Dickinson BP, Feller A, et al. (1999). "The infectious complications of anabolic-androgenic steroid injection." Int J Sports Med 20(8):563-566.

4. Rich JD, Dickinson BP, Flanigan TP, et al. (1999). "Abscess related to anabolic-androgenic steroid injection." Med Sci Sports Exerc 31(2):207-209.

5. Rich JD, Foisie CK, Towe CW, et al. (1999). "Needle exchange program participation by anabolic steroid injectors, United States 1998." Drug Alcohol Depend 56(2):157-160.

6. Rich JD, Mylonakis E, Nossa R, et al. (1999). "Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C." Dig Dis Sci 44(5):1034-1037.

7. Spaulding AC, Lally M, Rich JD, et al. (1999). "Hepatitis B and C in the context of HIV disease: implications for incarcerated populations." AIDS Read 9(7):481-491.

8. Rich JD, Foisie CK, Towe CW, et al. (2000). "High street prices of syringes correlate with strict syringe possession laws." Am J Drug Alcohol Abuse 26(3):481-487.

9. Cannon MJ, Dollard SC, Smith DK, et al. (2001). "Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection." N Engl J Med 344(9):637-643.

10. Charuvastra A, Stein J, Schwartzapfel B, et al. (2001). "Hepatitis B vaccination practices in state and federal prisons." Public Health Rep 116(3):203-209.

11. Stein MD, Maksad J, Clarke J. (2001). "Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment." Drug Alcohol Depend 61(3):211-215.

12. Thomas DL, Rich JD, Schuman P, et al. (2001). "Multicenter evaluation of hepatitis C RNA levels among female injection drug users." J Infect Dis 183(6):973-976.

13. Feller E, Taylor LE. (2002). "Ten things you may not know about hepatitis C infection." Med Health R I 85(6):180-181.

14. Rich JD, Martin EG, Macalino GE, et al. (2002). "Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island." J Am Pharm Assoc (Wash) 42(6 Suppl 2):S58-61.

15. Rich JD, Wolf FA, Macalino G. (2002). "Strategies to improve access to sterile syringes for injection drug users." AIDS Read 12(12):527-535.

16. Taylor LE, Costello T, Alt E, et al. (2002). "Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals." AIDS 16(12):1700-1701.

17. Allen SA, Spaulding AC, Osei AM, et al. (2003). "Treatment of chronic hepatitis C in a state correctional facility." Ann Intern Med 138(3):187-190.

18. Clarke J, Schwartzapfel B, Pomposelli J, et al. (2003). "Hepatitis B vaccination of incarcerated women: a pilot program." J Health Care Poor Underserved 14(3):318-323.

19. Mayer KH, Hogan JW, Smith D, et al. (2003). "Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy." J Acquir Immune Defic Syndr 33(5):614-624.

20. Rich JD, Ching CG, Lally MA, et al. (2003). "A review of the case for hepatitis B vaccination of high-risk adults." Am J Med 114(4):316-318.

21. Stancliff S, Agins B, Rich JD, et al. (2003). "Syringe access for the prevention of blood borne infections among injection drug users." BMC Public Health 3:37.

22. Taylor LE, Schwartzapfel B, Allen S, et al. (2003). "Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence." Clin Infect Dis 36(11):1501-1502; author reply 1502-1503.

23. Macalino GE, Vlahov D, Sanford-Colby S, et al. (2004). "Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons." Am J Public Health 94(7):1218-1223.

24. Rich JD, McKenzie M, Macalino GE, et al. (2004). "A syringe prescription program to prevent infectious disease and improve health of injection drug users." J Urban Health 81(1):122-134.

25. Rich JD, Taylor LE, Allen SA. (2004). "Screening for hepatitis C virus infection in adults." Ann Intern Med 141(7):575-576; author reply 576.

26. Taylor LE, Rich JD, Tashima KT. (2004). "Peginterferon plus ribavirin for hepatitis C in HIV-infected patients." N Engl J Med 351(22):2340-2342; author reply 2340-2342.

27. Vallabhaneni S, Macalino GE, Reinert SE, et al. (2004). "Prisoners' attitudes toward Hepatitis B vaccination." Prev Med 38(6):828-833.

28. Boutwell AE, Allen SA, Rich JD. (2005). "Opportunities to address the hepatitis C epidemic in the correctional setting." Clin Infect Dis 40 Suppl 5:S367-372.

29. Edlin BR, Kresina TF, Raymond DB, et al. (2005). "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users." Clin Infect Dis 40 Suppl 5:S276-285.

30. Flanigan TP, Taylor LE, Mitty JA. (2005). "Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection." Clin Infect Dis 40 Suppl 5:S346-348.

31. Lally MA, MacNevin R, Sergie Z, et al. (2005). "A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center." AIDS Patient Care STDS 19(5):298-305.

32. Macalino GE, Dhawan D, Rich JD. (2005). "A missed opportunity: hepatitis C screening of prisoners." Am J Public Health 95(10):1739-1740.

33. Macalino GE, Vlahov D, Dickinson BP, et al. (2005). "Community incidence of hepatitis B and C among reincarcerated women." Clin Infect Dis 41(7):998-1002.

34. Rich JD, McKenzie M, Shield DC, et al. (2005). "Linkage with methadone treatment upon release from incarceration: a promising opportunity." J Addict Dis 24(3):49-59.

35. Taylor LE. (2005). "Delivering care to injection drug users coinfected with HIV and hepatitis C virus." Clin Infect Dis 40 Suppl 5:S355-361.

36. Taylor LE, Gholam PM, Schwartzapfel B, et al. (2005). "Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report." AIDS Read 15(11):629-631, 634-626, 638.

37. Zaller N, Noak A, Poshkus M, et al. (2005). "The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island." Med Health R I 88(12):424-427.

38. Hammer SM, Saag MS, Schechter M, et al. (2006). "Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel." JAMA 296(7):827-843.

39. Lai AR, Tashima KT, Taylor LE. (2006). "Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus." AIDS Patient Care STDS 20(10):678-692.

40. McGovern BH, Ditelberg JS, Taylor LE, et al. (2006). "Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients." Clin Infect Dis 43(3):365-372.

41. Pugatch D, Anderson BJ, O'Connell JV, et al. (2006). "HIV and HCV testing for young drug users in Rhode Island." J Adolesc Health 38(3):302-304.

42. Rich JD, Anderson BJ, Schwartzapfel B, et al. (2006). "Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users." Epidemiol Infect 134(3):478-484.

43. Vallabhaneni S, Macalino GE, Reinert SE, et al. (2006). "Prisoners favour hepatitis C testing and treatment." Epidemiol Infect 134(2):243-248.

44. Brim N, Zaller N, Taylor LE, et al. (2007). "Twinrix vaccination schedules among injecting drug users." Expert Opin Biol Ther 7(3):379-389.

45. Rich JD, Hogan JW, Wolf F, et al. (2007). "Lower syringe sharing and re-use after syringe legalization in Rhode Island." Drug Alcohol Depend 89(2-3):292-297.

46. Spaulding AC, Allen SA, Stone A. (2007). "Mortality after release from prison." N Engl J Med 356(17):1785; author reply 1786-1787.

47. Stein MD, Dubyak P, Herman D, et al. (2007). "Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative." Am J Drug Alcohol Abuse 33(4):517-525.

48. Tedeschi SK, Bonney LE, Manalo R, et al. (2007). "Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines." Public Health Rep 122(1):44-48.